Beta Drugs Limited

NSEI:BETA 주식 보고서

시가총액: ₹20.6b

Beta Drugs 관리

관리 기준 확인 4/4

Beta Drugs CEO는 Rahul Batra, Jan2021 에 임명되었습니다 의 임기는 3.83 년입니다. 총 연간 보상은 ₹ 12.10M, 100% 로 구성됩니다. 100% 급여 및 0% 보너스(회사 주식 및 옵션 포함). 는 ₹ 84.99M 가치에 해당하는 회사 주식의 0.41% 직접 소유합니다. 84.99M. 경영진과 이사회의 평균 재임 기간은 각각 3.8 년과 7.3 년입니다.

주요 정보

Rahul Batra

최고 경영자

₹12.1m

총 보상

CEO 급여 비율100.0%
CEO 임기3.8yrs
CEO 소유권0.4%
경영진 평균 재임 기간3.8yrs
이사회 평균 재임 기간7.3yrs

최근 관리 업데이트

Recent updates

Why Investors Shouldn't Be Surprised By Beta Drugs Limited's (NSE:BETA) 30% Share Price Surge

Nov 08
Why Investors Shouldn't Be Surprised By Beta Drugs Limited's (NSE:BETA) 30% Share Price Surge

Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

Aug 30
Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

Investors Appear Satisfied With Beta Drugs Limited's (NSE:BETA) Prospects As Shares Rocket 27%

Aug 30
Investors Appear Satisfied With Beta Drugs Limited's (NSE:BETA) Prospects As Shares Rocket 27%

Earnings Tell The Story For Beta Drugs Limited (NSE:BETA) As Its Stock Soars 29%

Dec 23
Earnings Tell The Story For Beta Drugs Limited (NSE:BETA) As Its Stock Soars 29%

Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

Dec 11
Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Jul 29
These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Here's Why We Think Beta Drugs (NSE:BETA) Is Well Worth Watching

Jun 17
Here's Why We Think Beta Drugs (NSE:BETA) Is Well Worth Watching

Here's Why I Think Beta Drugs (NSE:BETA) Might Deserve Your Attention Today

Feb 21
Here's Why I Think Beta Drugs (NSE:BETA) Might Deserve Your Attention Today

Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

Dec 20
Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Beta Drugs (NSE:BETA) Is Interesting

Nov 21
With EPS Growth And More, Beta Drugs (NSE:BETA) Is Interesting

These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Sep 02
These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

May 20
Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

Is Beta Drugs (NSE:BETA) A Risky Investment?

Jan 29
Is Beta Drugs (NSE:BETA) A Risky Investment?

Is Beta Drugs Limited's (NSE:BETA) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Dec 25
Is Beta Drugs Limited's (NSE:BETA) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)

Nov 20
Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)

CEO 보상 분석

Rahul Batra 의 보수는 Beta Drugs 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

₹410m

Jun 30 2024n/an/a

₹387m

Mar 31 2024₹12m₹12m

₹364m

Dec 31 2023n/an/a

₹356m

Sep 30 2023n/an/a

₹348m

Jun 30 2023n/an/a

₹327m

Mar 31 2023₹12mn/a

₹307m

Dec 31 2022n/an/a

₹298m

Sep 30 2022n/an/a

₹289m

Jun 30 2022n/an/a

₹269m

Mar 31 2022₹8m₹8m

₹248m

Dec 31 2021n/an/a

₹216m

Sep 30 2021n/an/a

₹183m

Jun 30 2021n/an/a

₹150m

Mar 31 2021₹6m₹6m

₹117m

Dec 31 2020n/an/a

₹106m

Sep 30 2020n/an/a

₹95m

Jun 30 2020n/an/a

₹94m

Mar 31 2020₹5m₹5m

₹94m

Sep 30 2019n/an/a

₹97m

Jun 30 2019n/an/a

₹89m

Mar 31 2019₹1m₹1m

₹80m

보상 대 시장: Rahul 의 총 보상 ($USD 143.26K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 187.40K ).

보상과 수익: Rahul 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Rahul Batra (41 yo)

3.8yrs

테뉴어

₹12,100,000

보상

Mr. Rahul Batra serves as the Chairman & Managing Director of Beta Drugs Limited since January 27, 2021. He had been Whole Time Director of Beta Drugs Limited since August 1, 2014 until January 27, 2021. H...

리더십 팀

이름위치테뉴어보상소유권
Rahul Batra
Chairman & MD3.8yrs₹12.10m0.41%
₹ 85.0m
Varun Batra
Joint MD & Whole Time Director3.8yrs₹12.10m0.35%
₹ 71.2m
Nipun Arora
Chief Financial Officer3.7yrs₹3.10m데이터 없음
Rajni Brar
Company Secretary & Compliance Officer7.3yrs₹911.55k데이터 없음
Ashutosh Shukla
VP of Sales & Marketing and Whole Time Director5.7yrs₹5.12m데이터 없음
Seema Chopra
Whole Time Directorno data₹1.19m데이터 없음
Sanjeev Chopra
Vice President of Technicalno data데이터 없음데이터 없음

3.8yrs

평균 재임 기간

40.5yo

평균 연령

경험이 풍부한 관리: BETA 의 관리팀은 경험 ( 3.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Rahul Batra
Chairman & MD10.3yrs₹12.10m0.41%
₹ 85.0m
Varun Batra
Joint MD & Whole Time Director10.3yrs₹12.10m0.35%
₹ 71.2m
Ashutosh Shukla
VP of Sales & Marketing and Whole Time Director2.8yrs₹5.12m데이터 없음
Seema Chopra
Whole Time Director5.3yrs₹1.19m데이터 없음
Manmohan Khanna
Independent Director7.3yrs데이터 없음데이터 없음
Rohit Parti
Independent Director7.3yrs데이터 없음데이터 없음

7.3yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 이사회: BETA 의 이사회는 경험(평균 재직 기간 7.3 년)으로 간주됩니다.